Lung Cancer Dispatch
4.5K views | +0 today
Follow
Lung Cancer Dispatch
News for Patients and Physicians
Curated by Cancer Commons
Your new post is loading...
Your new post is loading...
Suggested by Cancer Commons
Scoop.it!

Radiation Before Surgery May Increase Survival in Mesothelioma Patients

Radiation Before Surgery May Increase Survival in Mesothelioma Patients | Lung Cancer Dispatch | Scoop.it

A study in 25 patients with mesothelioma, a type of lung cancer associated with exposure to asbestos, suggests that radiation treatment before surgery can significantly increase survival. Patients were treated using a new approach dubbed SMART (Surgery for Mesothelioma After Radiation Therapy). They received an accelerated, 5-day course of intensity-modulated radiation therapy (IMRT), which conforms the radiation dose around the tumors while sparing nearby healthy tissues. They then underwent surgery to remove the affected lung. Seventy-two percent of patients survived 3 years or more after treatment; 3-year survival rates without SMART rank at 32%. People with known exposure to asbestos who experience shortness of breath, weight loss, and fatigue for more than 3 weeks should be evaluated by a doctor to ensure speedy access to treatment.

Cancer Commons's insight:

ScienceDaily  |  Jan 20, 2014

more...
No comment yet.
Suggested by Cancer Commons
Scoop.it!

Advocacy Group: Lung Cancer Patients Who Have Been Exposed to Asbestos May be Eligible for Compensation

Advocacy Group: Lung Cancer Patients Who Have Been Exposed to Asbestos May be Eligible for Compensation | Lung Cancer Dispatch | Scoop.it

The Lung Cancer Asbestos Victims Center has launched a national campaign emphasizing that patients diagnosed with any type of lung cancer, not just mesothelioma, may be eligible for significant financial compensation if they have been exposed to asbestos in the workplace, even if the exposure occurred decades ago. The advocacy group lists the types of workplaces with the highest risk of asbestos exposure on their website. Patients or their family members can contact the organization at 866-714-6466 to get more information and to be directed to an experienced law firm.

Cancer Commons's insight:

PRWeb | Jan 31, 2013

more...
No comment yet.
Suggested by Cancer Commons
Scoop.it!

Two New Trials of Mesothelioma Treatments Begin in the UK

Mesothelioma is a form of lung cancer strongly associated with exposure to asbestos. Even though asbestos has been banned or heavily regulated in most developed nations, due to delayed onset, the number of mesothelioma cases is predicted to climb until around 2020. In the UK, which has the highest mesothelioma incidence worldwide, two new clinical trials are aiming to find treatments for the disease. The Meso2 trial will investigate ganetespib, while the COMMAND trial will examine defactinib. Defactinib specifically targets cancer stem cells, which often survive cancer treatment and cause cancer recurrence. The drug may therefore help prevent relapse after first-line therapy.

Cancer Commons's insight:

ScienceDaily | Sep 23, 2013

more...
No comment yet.